Novamsc-EyRIS has obtained a global foot print in 8 countries (Brazil being the latest one), and there are >20 countries that are currently work in progress.
I think currently all medical spendings are focusing on fighting COVID, once the pendamic is over, believe that EyRIS will start to realise it's potential.
SELENA+ received regulatory approval for commercialisation from ANVISA (Agência Nacional de Vigilância Sanitária) or the National Health Surveillance Agency. ANVISA is the regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices in Brazil.
Brazil is one of the 20 countries of the International Diabetes Federation (IDF) South America/Central America (SACA) region. According to IDF’s latest statistics, 463 million people have diabetes in the world and more than 32 million people in the SACA Region; by 2045 this will rise to 49 million. Brazil has a population of 210 million and a diabetic prevalence of about 12%.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Twowah123
654 posts
Posted by Twowah123 > 2020-10-21 14:39 | Report Abuse
Lookinh good. Today might break 0.115